Factory Supply Raw Material 99% Powder CAS 174671-46-6 Tavaborole
Product Description
| Product name | Tavaborole |
| CAS | 174671-46-6 |
| Appearance | white powder |
| Assay | 99% |
| Storage | Cool and Protect from light |
Tavaborole, also known as AN-2690 is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole began its Phase 3 trials in December 2010 and was approved in July 2014.
Tavaborole inhibits an essential fungal enzyme, Leucyl-tRNA synthetase, or LeuRS, required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and cell death, eliminating the fungal infection. No treatment-related systemic side effects were observed in any of its clinical trials.
